Auna S.A.

NYSE:AUNA Stock Report

Market Cap: US$366.4m

Auna Past Earnings Performance

Past criteria checks 1/6

Auna has been growing earnings at an average annual rate of 20.7%, while the Healthcare industry saw earnings growing at 4% annually. Revenues have been growing at an average rate of 21.2% per year. Auna's return on equity is 4.3%, and it has net margins of 1.5%.

Key information

20.74%

Earnings growth rate

12.99%

EPS growth rate

Healthcare Industry Growth8.50%
Revenue growth rate21.24%
Return on equity4.30%
Net Margin1.52%
Last Earnings Update31 Mar 2026

Recent past performance updates

Analysis Article May 28

Some Investors May Be Willing To Look Past Auna's (NYSE:AUNA) Soft Earnings

Investors were disappointed with the weak earnings posted by Auna S.A. ( NYSE:AUNA ). Despite the soft profit numbers...

Recent updates

Narrative Update Jun 01

AUNA: Mexico Execution And 2026 Guidance Will Drive Bullish Re Rating

Analysts have reduced their price target on Auna by $1 to $5, reflecting updated assumptions for fair value, discount rate, growth, margins, and future P/E following a worse than expected Q1 report. What's in the News Auna issued new earnings guidance for fiscal year 2026, projecting revenue growth of about 12% on a constant currency basis, within a range of 10% to 14%.
Seeking Alpha May 29

Auna: A Discounted Hospital Operator With An Insurance Twist

Summary Auna trades at depressed valuations despite a stable, integrated insurance and hospital business spanning Peru, Colombia, and Mexico. Operational setbacks in Mexico and Colombia have pressured results, but recent management actions and Q1 trends indicate stabilization and recovery potential. AUNA’s leverage remains high (net debt/EBITDA 3.7x), but recent debt restructuring, improved cash generation, and reduced capex support deleveraging. With a P/FCF of 1.9x and P/E of 5x (2026E), AUNA offers material upside if operational and macro risks continue to abate. Read the full article on Seeking Alpha
Analysis Article May 28

Some Investors May Be Willing To Look Past Auna's (NYSE:AUNA) Soft Earnings

Investors were disappointed with the weak earnings posted by Auna S.A. ( NYSE:AUNA ). Despite the soft profit numbers...
Narrative Update May 04

AUNA: Execution On 2026 Guidance Will Drive Reassessment Of Bearish Reset

Analysts have reduced their price target on Auna from $19.00 to $9.00, citing updated assumptions for discount rate, revenue growth, profit margins, and a lower future P/E following recent bearish Street research. Analyst Commentary Even with the lower headline target, some bullish analysts still see room for upside if Auna can deliver on key execution milestones and support the revised valuation assumptions.
Narrative Update Apr 19

AUNA: Mexico Execution And 2026 Guidance Will Support Bullish Re‑Rating

Analysts have maintained their price target on Auna at $7.20, citing a mix of more cautious and more optimistic research views that reflect slightly updated assumptions for discount rates, growth and P/E multiples. Analyst Commentary Bullish Takeaways Bullish analysts point to the current $7.20 target as reasonable relative to their updated P/E assumptions, suggesting the valuation still lines up with their expectations for the business model and capital allocation.
Narrative Update Apr 05

AUNA: Mexico Execution And 2026 Guidance Will Support Long-Term Upside

Analysts have trimmed their price target for Auna from about $10.42 to $7.20, reflecting updated views on discount rates, revenue growth, profit margins and future P/E, following a mix of recent bullish and bearish research updates. Analyst Commentary Recent research on Auna shows a mix of optimism and caution, which helps explain the reduced price target and the current debate around the shares.
Narrative Update Mar 22

AUNA: Mixed Research Views And 2026 Guidance Will Shape Execution Outlook

Auna's analyst price target has been updated to $6.00, with analysts citing mixed recent research that includes a more cautious stance from BTG Pactual, along with more constructive views from HSBC and Jefferies on the company outlook. Analyst Commentary Recent Street research on Auna points to a split view, with some analysts turning more constructive while others are sounding more cautious and adjusting ratings and price targets accordingly.
Narrative Update Mar 08

AUNA: Execution On Mixed Research Views Will Shape Future Upside Potential

Analysts have trimmed their Auna price target to $6.00, reflecting slightly adjusted assumptions around the discount rate, revenue growth, profit margins and future P/E after a mix of more cautious and more constructive recent research views. Analyst Commentary Recent research views on Auna have moved in different directions, with some firms turning more constructive and at least one becoming more cautious.
Narrative Update Feb 22

AUNA: Execution On Mixed Mexico Expansion Views Will Drive Future Upside

Analysts have nudged their price target on Auna up from $6.00 to $6.50, reflecting mixed but generally constructive research, with one firm turning more cautious even as others highlight potential for slightly better growth, margins, and a lower assumed future P/E. Analyst Commentary Recent research has not been uniformly positive, and some bearish analysts are clearly leaning more cautious on Auna, even as others highlight potential upside.
Narrative Update Feb 07

AUNA: Mexico Expansion And Leverage Execution Will Drive Upside Potential

Analysts have reduced their price target on Auna to $6.00 from $13.50, reflecting a more cautious stance as they weigh concerns about a slower ramp up in Mexico, elevated leverage, and mixed recent rating changes from BTG Pactual, HSBC, and Jefferies. Analyst Commentary Recent research shows a split in views on Auna, with some firms taking a more constructive stance while others highlight execution and balance sheet risks.
Narrative Update Jan 24

AUNA: Mexico Execution And Leverage Path Will Shape Balanced Upside Potential

Analysts have lifted their Auna price target to $6.00 from $6.00, keeping the fair value level steady while adjusting their view to reflect updated assumptions on discount rates, revenue growth, profit margins and future P/E in light of mixed but generally constructive recent research. Analyst Commentary Recent research on Auna has been mixed, with some firms taking a more constructive stance while others highlight ongoing execution and balance sheet questions.
Analysis Article Jan 23

Does Auna (NYSE:AUNA) Have A Healthy Balance Sheet?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Narrative Update Jan 10

AUNA: Mexico Expansion Will Reframe Perceived Execution And Leverage Risks

Analysts have trimmed their price target on Auna to US$6 from US$13.50, pointing to a slower ramp-up in Mexico, a less supportive consolidated growth profile, and expectations that leverage will remain elevated. Analyst Commentary Recent Street research on Auna has turned more cautious, with JPMorgan cutting its rating to Neutral and lowering its price target to US$6 from US$13.50.
Narrative Update Dec 22

AUNA: Mexico Execution And Deleveraging Will Drive Long-Term Upside Potential

Analysts have trimmed their price target on Auna by roughly $0.25 to reflect a slightly lower fair value estimate and a modestly higher discount rate, citing concerns over slower than expected growth and sustained leverage highlighted in recent research. Analyst Commentary Analyst reactions to the latest developments at Auna have focused on the trade off between long term growth optionality and near term execution risks, particularly around the company's regional expansion and balance sheet trajectory.
Narrative Update Dec 08

AUNA: Mexico Expansion And Deleveraging Will Unlock Future Upside Potential

Analysts have lowered their price target on Auna from $13.50 to $6.00, citing a slower than expected ramp-up in Mexico, a less compelling consolidated growth profile, and persistently elevated leverage. Analyst Commentary Analyst views on Auna have turned more cautious following the recent downgrade and target price cut to $6.00, but the stock’s reset valuation is also seen as creating a more balanced risk reward profile.
Narrative Update Nov 24

AUNA: Future Expansion Plans In Mexico Will Unlock Growth Potential

Narrative Update: Analyst Price Target Change for Auna The average analyst price target for Auna was reduced from $12.08 to $10.67. Analysts point to a slower than expected operational ramp-up and persistent elevated leverage as key factors for the adjustment.
Analysis Article Nov 14

Auna (NYSE:AUNA) Is Looking To Continue Growing Its Returns On Capital

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to...
User avatar
New Narrative May 29

High-Efficiency Healthcare Model And Demographic Trends Will Shape Future Landscape

Operational challenges in Mexico are being addressed, while strong performance in Peru showcases the potential of Auna's value-based, integrated care model.
Analysis Article Jan 29

A Piece Of The Puzzle Missing From Auna S.A.'s (NYSE:AUNA) 26% Share Price Climb

The Auna S.A. ( NYSE:AUNA ) share price has done very well over the last month, posting an excellent gain of 26%. While...
Analysis Article Jan 19

Here's Why Auna (NYSE:AUNA) Has A Meaningful Debt Burden

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Seeking Alpha Jan 15

Auna: Cheap Entry Level In Latin American Healthcare Play

Summary Auna is a leading player in the Spanish-speaking Latin America medical industry, focusing particularly on high-complexity diseases, such as cancer. Most SSLA have a highly fragmented and underserved healthcare market, and populations are becoming elderly, demanding more and better services. AUNA stock has been impacted negatively following its IPO process, as local institutional players such as pension funds overbought the stock and had to sell due to regulatory limits. AUNA stock trades currently below 6X EV / EBITDA, while revenues and EBITDA are growing at double digits. Patient investors should benefit from valuation normalization metrics and continued growth. Though it still has high leverage (Net Debt / EBITDA =3.7), it has been able to decrease it (from 6.8X in 2021) and has stable and growing operating cash flows (annual run rate USD250MM last quarter). Interest rate reductions should benefit the company. Read the full article on Seeking Alpha

Revenue & Expenses Breakdown

How Auna makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NYSE:AUNA Revenue, expenses and earnings (PEN Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 264,521691,1150
31 Dec 254,385981,0820
30 Sep 254,3161871,0420
30 Jun 254,3252371,0530
31 Mar 254,3521591,0350
31 Dec 244,3861101,0270
30 Sep 244,344-1231,0060
30 Jun 244,233-2619640
31 Mar 244,058-2639560
31 Dec 233,876-2549020
30 Sep 233,659-1128360
30 Jun 233,241-767690
31 Mar 232,861-1006740
31 Dec 222,452-866200
30 Sep 222,118-656260
30 Jun 222,009-646040
31 Mar 221,937-355940
31 Dec 211,924-265860
30 Sep 211,874205360
30 Jun 211,779424940
31 Mar 211,577514490
31 Dec 201,444-74210
30 Sep 201,373283960
30 Jun 201,335143880
31 Mar 201,381163850
31 Dec 191,383733750
31 Dec 18861362710
31 Dec 17723222440

Quality Earnings: AUNA has a large one-off loss of PEN63.1M impacting its last 12 months of financial results to 31st March, 2026.

Growing Profit Margin: AUNA's current net profit margins (1.5%) are lower than last year (3.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: AUNA has become profitable over the past 5 years, growing earnings by 20.7% per year.

Accelerating Growth: AUNA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: AUNA had negative earnings growth (-56.8%) over the past year, making it difficult to compare to the Healthcare industry average (17%).


Return on Equity

High ROE: AUNA's Return on Equity (4.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/12 08:46
End of Day Share Price 2026/06/12 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Auna S.A. is covered by 7 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Samuel Campos AlvesBTG Pactual
Leandro BastosCitigroup Inc
Raj SinhaHSBC